<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29046876</article-id><article-id pub-id-type="pmc">5634946</article-id><article-id pub-id-type="publisher-id">92</article-id><article-id pub-id-type="doi">10.1186/s41038-017-0092-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>The emergence of multidrug-resistant clone ST664 <italic>Pseudomonas aeruginosa</italic> in a referral burn hospital, Isfahan, Iran</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Vaez</surname><given-names>Hamid</given-names></name><address><email>hamidvaez@hotmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Safaei</surname><given-names>Hajieh Ghasemian</given-names></name><address><email>ghasemian@mui.ac.ir</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Faghri</surname><given-names>Jamshid</given-names></name><address><email>faghri@mui.ac.ir</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0384 898X</institution-id><institution-id institution-id-type="GRID">grid.444944.d</institution-id><institution>Department of Microbiology, School of Medicine, </institution><institution>Zabol University of Medical Sciences, </institution></institution-wrap>Zabol, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1498 685X</institution-id><institution-id institution-id-type="GRID">grid.411036.1</institution-id><institution>Department of Microbiology, School of Medicine, </institution><institution>Isfahan University of Medical Sciences, </institution></institution-wrap>Isfahan, Iran </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>5</volume><elocation-id>27</elocation-id><history><date date-type="received"><day>11</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>11</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003970</institution-id><institution>Isfahan University of Medical Sciences</institution></institution-wrap></funding-source><award-id>392063</award-id><principal-award-recipient><name><surname>Vaez</surname><given-names>Hamid</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par2">Dear editor,</p><p id="Par3">Treatment of infection caused by multidrug-resistant&#x000a0;(MDR) <italic>Pseudomonas aeruginosa</italic> (<italic>P. aeruginosa</italic>) strains due to simultaneously resistance to different class of antibiotics is a major burn unit concern worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. Multidrug-resistant isolates of <italic>P. aeruginosa</italic> (MDR-<italic>P. aeruginosa</italic>) are non-susceptible to at least three antibiotics belonged to different classes especially carbapenems, fluoroquinolones, and aminoglycosides [<xref ref-type="bibr" rid="CR2">2</xref>]. Since determination of clonal relatedness among bacterial infectious agents is an essential pre-requisite to take appropriate infection control practices, the aim of this study was to investigate the genetic diversity and document the presence of high-risk clone of MDR-<italic>P. aeruginosa</italic> in burn wound infections.</p><p id="Par4">A cross-sectional study was carried out between March 2013 and September 2013 at a referral burn hospital of Isfahan province, Iran. The hospital is&#x000a0;the only burn referral center in the region, serving about five million people. In total, 100 burn patients admitted to Intensive Care Unit (ICU) during period of study were included. During the study period, sterile swabs were used for sample collection from wounds of burn patients whom, based on clinical signs, we suspected had a wound infection. After identification, antibiotic resistance profile was determined by disk diffusion method. Finally, MDR-clone of identified <italic>P. aeruginosa</italic> was subjected to multi locus sequence typing (MLST), according to previously described procedures [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par5">The specimens of 30 (30%)&#x000a0;patients yielded bacterial growth. From these, 13 (43.3%) patients were female. The susceptibility patterns of isolated bacteria against applied antibiotics were as follows: ceftazidime (16.7%; 5/30), polymyxin B (100%; 30/30), gentamicin (73.3%; 22/30), piperacillin (6.7%; 2/30), ceftriaxone (6.7% 2/30), imipenem (73.3%; 22/30), ciprofloxacin (50%; 15/30), aztreonam (13.3%; 4/30), meropenem (70%; 21/30), and amikacin (73.3%; 22/30). Out of the 30 isolated strains of <italic>P. aeruginosa</italic>, 8 (26.7%) were MDR, showing resistance against all applied antibiotics except for polymyxin B. We found four different sequence types (STs); ST235, ST233, ST357, and ST664.</p><p id="Par6">In present study, <italic>P. aeruginosa</italic> isolates were mostly resistant against piperacillin (93.3%), ceftriaxone (93.3%), and aztreonam (86.7%). These findings are similar to other studies performed in Iran [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Salimi et al. reported that many isolates of <italic>P. aeruginosa</italic> collected from burn patients referred to Mottahari hospital in Tehran province were resistant to used antibiotics, ceftizoxime (87%), aztreonam (80.2%), kanamycin (79.4%), and ceftazidime (74.8%) [<xref ref-type="bibr" rid="CR6">6</xref>]. MLST of <italic>P. aeruginosa</italic> revealed that some MLST STs such as ST235, ST175, and ST111 are high risk and epidemic clones because these STs showed resistance against multiple different classes of antibiotics, also were associated with high mortality and morbidity rate worldwide [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Four different STs in MDR-<italic>P. aeruginosa</italic> were detected (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The most common type was ST664 and ST357, which were detected in four and two isolates, respectively. Other types including ST233 and ST235 were also detected in one isolate. The majority of our STs including ST233, ST664, and ST357 were identified for the&#x000a0;first time in Isfahan. Study conducted by Fazeli et al. in Isfahan province showed that the majority of MDR-clone of <italic>P. aeruginosa</italic> belonged to ST235 [<xref ref-type="bibr" rid="CR9">9</xref>]. Likewise, results of different independent studies revealed that ST235 is an&#x000a0;international clone and distributed worldwide [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. For example, Cholley et al. reported that ST235 was the most common MDR-clone isolated from France hospitals [<xref ref-type="bibr" rid="CR8">8</xref>]. In another study performed in different hospitals of Korea, ST235 was known to be the most frequent type with higher rate of non-susceptibility to different classes of antibiotics including penicillins, expanded-spectrum cephalosporins, carbapenems, aminoglycosides, and fluoroquinolones [<xref ref-type="bibr" rid="CR10">10</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of MDR-<italic>P. aeruginosa</italic> isolated from burn wound infection</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Isolates</th><th>Allelic profiles<break/>(<italic>acsA, aroE guaA, mutL, nuoD, ppsA, trpE</italic>)</th><th>ST</th><th>Antibiotic resistance pattern</th></tr></thead><tbody><tr><td>1</td><td>2-4-5-3-1-6-11</td><td>357</td><td>R: CAZ, IMP, MEM, CIP, ATM, PIP, AMK, GM</td></tr><tr><td>2</td><td>2-4-5-3-1-6-11</td><td>357</td><td>R: CAZ, IMP, MEM, CIP, ATM, PIP, AMK, GM</td></tr><tr><td>3</td><td>38-11-3-13-1-2-4</td><td>235</td><td>R: CAZ, IMP, MEM, CIP, ATM, PIP, AMK, GM</td></tr><tr><td>4</td><td>9-5-11-3-4-40-18</td><td>664</td><td>R: CAZ, IMP, MEM, CIP, ATM, PIP, AMK, GM</td></tr><tr><td>5</td><td>9-5-11-3-4-40-18</td><td>664</td><td>R: CAZ, IMP, MEM, CIP, ATM, PIP, AMK, GM</td></tr><tr><td>6</td><td>9-5-11-3-4-40-18</td><td>664</td><td>R: CAZ, IMP, MEM, CIP, ATM, PIP, AMK, GM</td></tr><tr><td>7</td><td>9-5-11-3-4-40-18</td><td>664</td><td>R: CAZ, IMP, MEM, CIP, ATM, PIP, AMK, GM</td></tr><tr><td>8</td><td>16-5-30-11-4-31-41</td><td>233</td><td>R: CAZ, IMP, MEM, CIP, ATM, PIP, AMK, GM</td></tr></tbody></table><table-wrap-foot><p>
<italic>MDR-P. aeruginosa</italic> Multidrug-resistant isolates of <italic>P. aeruginosa</italic>, <italic>ST</italic> sequence type, <italic>R</italic> resistance, <italic>CAZ</italic> ceftazidime, <italic>IMP</italic> imipenem, <italic>MEM</italic> meropenem, <italic>CIP</italic> ciprofloxacin, <italic>ATM</italic> aztreonam, <italic>PIP</italic> piperacillin, <italic>AMK</italic> amikacin, <italic>GM</italic> gentamicin</p></table-wrap-foot></table-wrap>
</p></body><back><ack><title>Acknowledgements</title><p>We are grateful to Ms. Beige for her excellent assistant.</p><sec id="FPar1"><title>Funding</title><p id="Par7">This work was partially funded by a grant (no. 392063) from the Isfahan University of Medical Sciences.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par8">The data used in this publication is kept by authors and is available upon request.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>The study design was performed by HV, HGS, and JF. The laboratory test was performed by HV. The interpretation of results was done by HV and HGS. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethic approval and consent to participate</title><p id="Par9">This study was confirmed by ethics committee of Isfahan University of Medical Sciences.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par10">Not applicable</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par11">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossolini</surname><given-names>GM</given-names></name><name><surname>Mantengoli</surname><given-names>E</given-names></name></person-group><article-title>Treatment and control of severe infections caused by multiresistant <italic>Pseudomonas aeruginosa</italic></article-title><source>Clin Microbiol Infect</source><year>2005</year><volume>11</volume><fpage>17</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2005.01161.x</pub-id><pub-id pub-id-type="pmid">15953020</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magiorakos</surname><given-names>AP</given-names></name><name><surname>Srinivasan</surname><given-names>A</given-names></name><name><surname>Carey</surname><given-names>RB</given-names></name><name><surname>Carmeli</surname><given-names>Y</given-names></name><name><surname>Falagas</surname><given-names>ME</given-names></name><name><surname>Giske</surname><given-names>CG</given-names></name><name><surname>Harbarth</surname><given-names>S</given-names></name></person-group><article-title>Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</article-title><source>Clin Microbiol Infect</source><year>2012</year><volume>18</volume><fpage>268</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03570.x</pub-id><pub-id pub-id-type="pmid">21793988</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>B</given-names></name><name><surname>Jonas</surname><given-names>D</given-names></name><name><surname>Grundmann</surname><given-names>H</given-names></name><name><surname>Pitt</surname><given-names>T</given-names></name><name><surname>Dowson</surname><given-names>CG</given-names></name></person-group><article-title>Development of a multilocus sequence typing scheme for the opportunistic pathogen <italic>Pseudomonas aeruginosa</italic></article-title><source>J Clin Microbiol</source><year>2004</year><volume>42</volume><issue>12</issue><fpage>5644</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1128/JCM.42.12.5644-5649.2004</pub-id><pub-id pub-id-type="pmid">15583294</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaez</surname><given-names>H</given-names></name><name><surname>Beigi</surname><given-names>F</given-names></name></person-group><article-title>Antibiotic susceptibility patterns of aerobic bacterial strains isolated from patients with burn wound infections</article-title><source>Germs</source><year>2016</year><volume>6</volume><issue>1</issue><fpage>34</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.11599/germs.2016.1087</pub-id><pub-id pub-id-type="pmid">27019830</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikokar</surname><given-names>I</given-names></name><name><surname>Tishayar</surname><given-names>A</given-names></name><name><surname>Flakiyan</surname><given-names>Z</given-names></name><name><surname>Alijani</surname><given-names>K</given-names></name><name><surname>Banisaeed</surname><given-names>SR</given-names></name><name><surname>Hoseinpour</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antibiotic resistance and frequency of class 1 integrons among Pseudomonas aeruginosa, isolated from burn patients in Guilan, Iran</article-title><source>Iran J Microbiol</source><year>2013</year><volume>5</volume><issue>1</issue><fpage>36</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">23466812</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salimi</surname><given-names>H</given-names></name><name><surname>Yakhchali</surname><given-names>B</given-names></name><name><surname>Owlia</surname><given-names>P</given-names></name><name><surname>Abdolaziz Rastegar</surname><given-names>L</given-names></name></person-group><article-title>Molecular epidemiology and drug susceptibility of <italic>Pseudomonas aeruginosa</italic> strains isolated from burn patients</article-title><source>Lab Med</source><year>2010</year><volume>41</volume><issue>9</issue><fpage>540</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1309/LMNIJE31EDC1WAMP</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulet</surname><given-names>X</given-names></name><name><surname>Cabot</surname><given-names>G</given-names></name><name><surname>Ocampo-Sosa</surname><given-names>AA</given-names></name><name><surname>Dominguez</surname><given-names>MA</given-names></name><name><surname>Zamorano</surname><given-names>L</given-names></name><name><surname>Juan</surname><given-names>C</given-names></name><etal/></person-group><article-title>Biological markers of <italic>Pseudomonas aeruginosa</italic> epidemic high-risk clones</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><issue>11</issue><fpage>5527</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1128/AAC.01481-13</pub-id><pub-id pub-id-type="pmid">23979744</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cholley</surname><given-names>P</given-names></name><name><surname>Thouverez</surname><given-names>M</given-names></name><name><surname>Hocquet</surname><given-names>D</given-names></name><name><surname>Mee-Marquet</surname><given-names>ND</given-names></name><name><surname>Talon</surname><given-names>D</given-names></name><name><surname>Bertrand</surname><given-names>X</given-names></name></person-group><article-title>Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in Eastern France belong to a few clonal types</article-title><source>J Clin Microbiol</source><year>2011</year><volume>49</volume><issue>7</issue><fpage>2578</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1128/JCM.00102-11</pub-id><pub-id pub-id-type="pmid">21593258</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazeli</surname><given-names>H</given-names></name><name><surname>Sadighian</surname><given-names>H</given-names></name><name><surname>Esfahani</surname><given-names>BN</given-names></name><name><surname>Pourmand</surname><given-names>MR</given-names></name></person-group><article-title>Molecular epidemiology and mechanisms of antimicrobial resistance in Pseudomonas aeruginosa isolates causing burn wound infection in Iran</article-title><source>J Chemother</source><year>2014</year><volume>26</volume><issue>4</issue><fpage>222</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1179/1973947813Y.0000000132</pub-id><pub-id pub-id-type="pmid">24070432</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>IK</given-names></name><name><surname>Suh</surname><given-names>B</given-names></name><name><surname>Jeong</surname><given-names>SH</given-names></name><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Kim</surname><given-names>YR</given-names></name><name><surname>Yong</surname><given-names>D</given-names></name><etal/></person-group><article-title>Molecular epidemiology of <italic>Pseudomonas aeruginosa</italic> clinical isolates from Korea producing &#x000df; -lactamases with extended-spectrum activity</article-title><source>Diagn Microbiol Infect Dis</source><year>2014</year><volume>79</volume><fpage>373</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2014.03.007</pub-id><pub-id pub-id-type="pmid">24792837</pub-id></element-citation></ref></ref-list></back></article>